Aptevo Therapeutics Inc.APVONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank73
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-23.79M
↑ 28% vs avg
Percentile
P73
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-32.85M
Historical baseline
PeriodValueYoY Change
2024$-23.79M-102.8%
2023$-11.73M+44.2%
2022$-21.02M+3.0%
2021$-21.68M+26.1%
2020$-29.32M+30.8%
2019$-42.38M+17.6%
2018$-51.42M-23.7%
2017$-41.57M-12.8%
2016$-36.86M+24.4%
2015$-48.76M-